US Patent 9527905 Antibodies that specifically bind
Patent 9527905 was granted and assigned to MedImmune on December, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+147 characters)
Article
Patent abstract
Herein provided are compositions, methods of manufacture and methods of use pertaining to anti-alpha toxin antibodies and fragments.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Bret Sellman0
Christine Tkaczyk0
Jamese Johnson Hilliard0
Lei Hua0
Li Peng0
Melissa Damschroder0
Partha Chowdhury0
Reena Varkey0
Vaheh Oganesyan0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09527905 Antibodies that specifically bind US Patent 9527905 Antibodies that specifically bind
Infobox
Patent Number
095279050
Patent Number
95279050
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
095279050
Date of Patent
December 27, 2016
0Patent Application Number
139838040
Date Filed
February 7, 2012
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09527905 Antibodies that specifically bind
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09527905
Date of patent
December 27, 2016
Patent application number
13983804
Date Filed
February 7, 2012
Patent primary examiner
Find more entities like US Patent 9527905 Antibodies that specifically bind
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
